Three-year OCT predictive factors of disease recurrence in eyes with successfully treated myopic choroidal neovascularisation

医学 眼科 视力 回顾性队列研究 人口统计学的 队列 黄斑变性 眼病 外科 内科学 人口学 社会学
作者
Enrico Borrelli,Marco Battista,Giovanna Vella,Riccardo Sacconi,Lea Querques,Domenico Grosso,Francesco Bandello,Giuseppe Querques
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:: bjophthalmol-318440
标识
DOI:10.1136/bjophthalmol-2020-318440
摘要

To assess the relationship of demographics, clinical characteristics and structural optical coherence tomography (OCT) findings to disease recurrence in a cohort of patients with newly diagnosed myopic choroidal neovascularisation (CNV) METHODS: In this retrospective, longitudinal study, a total of 64 participants (64 eyes) with successfully treated myopic CNV had obtained resolution of exudation after treatment (study baseline) and with 3 years of regular follow-ups. Several baseline OCT qualitative features and quantitative measurements were assessed at baseline and included in the analysis. Main outcome measures included incidence of disease recurrence and HR for demographics, clinical characteristics and OCT risk factors.At month 36, 40 eyes (62.5%) developed disease recurrence (active CNV). Multivariate linear regression analysis revealed that final visual acuity (dependent variable) was associated with visual acuity at the first visit after complete resolution of exudation (p<0.0001), baseline size of patchy atrophy (p=0.010), baseline subfoveal choroidal thickness (p=0.008), baseline maximum CNV height and width (p=0.011 and p=0.003) and recurrence of CNV exudation (p=0.007). The following factors were associated with an increased risk of disease recurrence: size of patchy atrophy had an HR of 1.14 (95% CI 1.01 to 1.29; p=0.036); maximum CNV width had an HR of 1.02 (95% CI 1.01 to 1.04; p<0.0001).We identified OCT risk factors for the disease recurrence in eyes with successfully treated myopic CNV. Assuming that disease recurrence is a sight-threatening event, our findings may help in the identification of high-risk patients and eventually ameliorate their outcome.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
毛豆爸爸完成签到 ,获得积分0
1秒前
丘比特应助哈哈采纳,获得10
1秒前
Zzzooo完成签到,获得积分10
2秒前
shuyu完成签到 ,获得积分10
3秒前
claire发布了新的文献求助20
3秒前
Zzzooo发布了新的文献求助10
5秒前
Cmy发布了新的文献求助10
8秒前
深情安青应助cjlinhunu采纳,获得10
8秒前
9秒前
马华化完成签到,获得积分0
9秒前
AdventureChen完成签到 ,获得积分10
10秒前
小王完成签到,获得积分10
10秒前
12秒前
完美行云完成签到,获得积分10
13秒前
16秒前
西柚发布了新的文献求助10
16秒前
853225598完成签到,获得积分10
17秒前
17秒前
静静静完成签到,获得积分20
18秒前
19秒前
哈哈发布了新的文献求助10
21秒前
adeno发布了新的文献求助10
21秒前
辣味尖尖酱完成签到 ,获得积分10
21秒前
田様应助小王采纳,获得10
22秒前
cctv18应助laser13采纳,获得10
23秒前
丘比特应助西柚采纳,获得10
24秒前
cjlinhunu发布了新的文献求助10
24秒前
贫穷的塔姆完成签到,获得积分10
24秒前
myc发布了新的文献求助10
27秒前
科目三应助adeno采纳,获得10
27秒前
27秒前
有魅力的大船完成签到,获得积分10
29秒前
萧勒完成签到,获得积分10
31秒前
青岩完成签到 ,获得积分10
31秒前
zpctx完成签到,获得积分10
31秒前
33秒前
大勺完成签到 ,获得积分10
34秒前
木樨完成签到,获得积分10
34秒前
AU完成签到 ,获得积分10
35秒前
36秒前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2546403
求助须知:如何正确求助?哪些是违规求助? 2175763
关于积分的说明 5600686
捐赠科研通 1896548
什么是DOI,文献DOI怎么找? 946341
版权声明 565379
科研通“疑难数据库(出版商)”最低求助积分说明 503569